In Hypertension (high blood pressure) LERVASC 10 MG TABLET is a calcium channel blocker. It works by relaxing the blood vessels so that blood can flow more easily around your body. This lowers your blood pressure and reduces your risk of having a stroke, a heart attack, or kidney problems in the future. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. Take regularly, as prescribed for this medicine to be most effective, even if you feel better.
Caution is advised when consuming alcohol with LERVASC 10 MG TABLET. Please consult your doctor.
LERVASC 10 MG TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
LERVASC 10 MG TABLET is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
LERVASC 10 MG TABLET may cause dizziness or weakness due to low blood pressure. Do not drive if these symptoms occur.
LERVASC 10 MG TABLET should be used with caution in patients with kidney disease. Dose adjustment of LERVASC 10 MG TABLET may be needed. Please consult your doctor. Use of LERVASC 10 MG TABLET is not recommended in patients with severe kidney disease.
LERVASC 10 MG TABLET should be used with caution in patients with liver disease. Dose adjustment of LERVASC 10 MG TABLET may be needed. Please consult your doctor. Use of LERVASC 10 MG TABLET is not recommended in patients with severe liver disease.
If you miss a dose of LERVASC 10 MG TABLET, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Aristo Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Glenmark Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)